tirzepatide device Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA How to use Mounjaro (tirzepatide)

Common side effects may include nausea, diarrhoea, decreased appetite, vomiting, constipation, indigestion, and stomach pain

Contraindications include personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as well as previous pancreatitis or severe GI disorders

For long-term benefits, regular maintenance may be recommended

"Melanoma immunotherapy"

Tirzepatide, a dual GLP-1 and GIP receptor agonist, addresses this cardiovascular threat through two interconnected mechanisms: sustained weight loss and direct improvements in arterial flexibility and heart workload

They primarily work by mimicking a gut hormone that slows digestion, reduces appetite, and improves insulin secretion